Advanced search
Publication Cover
ImmunoTargets and Therapy Volume 12, 2023 - Issue
Submit an article Journal homepage
1,107
Views
6
CrossRef citations to date
0
Altmetric
REVIEW

Novel Immunotherapies for Myasthenia Gravis

Sruthi S Nair1 Department of Neurology, University Hospitals Birmingham, Birmingham, B15 2TH, UK;2 Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India
&
Saiju Jacob1 Department of Neurology, University Hospitals Birmingham, Birmingham, B15 2TH, UK;3 Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0037-454X
ORCID Icon
Pages 25-45 | Received 08 Jan 2023, Accepted 03 Mar 2023, Published online: 04 Apr 2023

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alexandria Matic, Nouf Alfaidi & Vera Bril. (2023) An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis. Expert Opinion on Biological Therapy 23:12, pages 1163-1171.
Read now

Articles from other publishers (5)

Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Emilio Ciusani, Silvia Bonanno, Lorenzo Maggi, Annamaria Gallone, Anna Colasuonno, Irene Tramacere, Marta Cheli, Alessandro Pinna, Renato Mantegazza & Carlo Antozzi. (2024) Efgartigimod in generalized myasthenia gravis: A real‐life experience at a national reference center. European Journal of Neurology.
Crossref
Dong-Dong Meng, Zhe Ruan, Yong-Lan Tang, Zhao-Hua Ji, Yue Su, Tuo Xu, Bo-Zhou Cui, Da-Lin Ren, Ting Chang & Qian Yang. (2024) Factors associated with the disease family burden of caregivers of myasthenia gravis patients in northwestern China: A cross-sectional study. Journal of Clinical Neuroscience 119, pages 70-75.
Crossref
Rebecca Golfinopoulou, Véronique Giudicelli, Taciana Manso & Sofia Kossida. (2023) Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis. Vaccines 11:12, pages 1756.
Crossref
Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli, Francesca Andreetta, Renato Mantegazza & Carlo Antozzi. (2023) Efgartigimod improves triple-negative myasthenia gravis. Neurological Sciences.
Crossref
Cristina Georgiana Croitoru, Dan Iulian Cuciureanu, Diana Nicoleta Hodorog, Cristina Grosu & Petru Cianga. (2023) Autoimmune myasthenia gravis and COVID-19. A case report-based review. Journal of International Medical Research 51:8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.